Terug naar bedrijfspagina

Nieuws over IBA

21/11/2024 IBA - Business Update – Third Quarter 2024 (21.11.2024)

20/11/2024 IBA - signs contract with BENEBION for the installation of a Rhodotron® to equip a cutting-edge irradiation facility in Mexico (20.11.2024)

18/11/2024 IBA - Almathera selects IBA to equip Kazakhstan’s first private radiopharmacy and theranostics complex with Cyclone® KIUBE 300 (18.11.2024)

06/11/2024 IBA - signs contract with SteriLab for E-beam sterilisation solution in the Dominican Republic (06.11.2024)

29/10/2024 IBA - partners with Jubilant Radiopharma, selling five Cyclone KIUBE to support their PET radioisotope production across the US (29.10.2024)

03/10/2024 IBA - and Jules Bordet Institute to lead IHI project Accelerate.EU to create complete Astatine-211 value chain (03.10.2024)

11/09/2024 IBA - joint venture PanTera secures EUR 93 million in oversubscribed Series A round to accelerate global actinium-225 production (11.09.2024)

29/08/2024 IBA - Reports Half Year 2024 Results (29.08.2024)

27/08/2024 IBA - secures deal with the University of Pennsylvania Health System for two Proteus®ONE proton therapy solutions (27.08.2024)

02/08/2024 IBA – TRANSPARENCY NOTIFICATION (02.08.2024)

23/05/2024 IBA - Business Update – First Quarter 2024 (23.05.2024)

02/05/2024 IBA - signs contract with Yale New Haven Health and Hartford HealthCare to install Proteus®ONE proton therapy solution in Connecticut, US (02.05.2024)

11/04/2024 IBA – TRANSPARENCY NOTIFICATION (11.04.2024)

21/03/2024 IBA - Reports Full Year 2023 Results (21.03.2024)

19/03/2024 IBA - signs contract to install a Be-Efficient irradiation solution in Germany (19.03.2024)

29/02/2024 IBA - signs contract with IAEA for the installation of a Cyclone® KEY in Benin, West Africa (29.02.2024)

13/02/2024 IBA - PANTERA SIGNS AGREEMENT WITH BAYER FOR THE SUPPLY OF ACTINIUM-225 (13.02.2024)

09/02/2024 IBA - acquires Radcal Corporation to expand Medical Imaging Quality Assurance offering and strengthen US presence (09.02.2024)

01/02/2024 IBA - launches Oncia Community, a public utility foundation, dedicated to humanizing cancer care (01.02.2024)

23/01/2024 IBA - iThemba LABS ready to start production of Strontium-82 and Germanium-68 using IBA Cyclone 70 (23.01.2024)

05/12/2023 IBA - signs research collaboration agreement with the University of Kansas Medical Center on FLASH technology (05.12.2023)

16/11/2023 IBA - BUSINESS UPDATE – DERDE KWARTAAL 2023 (16.11.2023)

27/09/2023 IBA - finalizes contract with Medtechnica Ltd for two Proteus®ONE proton therapy solutions at the Tel Aviv Sourasky Medical Center in Israel (27.09.2023)

31/08/2023 IBA - Reports Half Year 2023 Results (31.08.2023)

26/06/2023 IBA - PANTERA EN TERRAPOWER ISOTOPES BUNDELEN DE KRACHTEN OM DE TOEGANG TOT ACTINIUM- 225 TE VERSNELLEN (26.06.2023)

15/06/2023 IBA - and PARTICLE initiate FLASH proton therapy Research Partnership (15.06.2023)

13/06/2023 IBA - signs contract with partner CGN Medical Technology for the installation of a Proteus®PLUS system in China (13.06.2023)

22/05/2023 IBA - signs Binding Term Sheet with Medtechnica Ltd for two Proteus®ONE proton therapy solutions at the Tel Aviv Sourasky Medical Center in Israel (22.05.2023)

17/05/2023 IBA - BUSINESS UPDATE – FIRST QUARTER 2023 (17.05.2023)

16/05/2023 IBA - Launches AKURACY an Integrated Solution for Cardiac PET Imaging at EACVI Meeting in Barcelona (16.05.2023)

23/03/2023 IBA - Reports Full Year 2022 Results (23.03.23)

10/01/2023 IBA - announces contract with Moffitt Cancer Center for a Proteus®ONE proton therapy solution in Florida, US (10.01.2023)

22/12/2022 IBA - signs contract to install a fully integrated X-ray irradiation solution in France (22.12.2022)

08/12/2022 IBA - Wins 10 Proton Therapy System Contract in Spain (08.12.2022)

17/11/2022 IBA - Business Update – Third Quarter 2022 (17.11.2022)

24/10/2022 IBA - Dosimetry expands its myQA iON technology into Radiation Therapy (24.10.2022)

20/10/2022 IBA - announces compatibility of its dosimetry solutions with Halcyon® and Ethos™ radiotherapy and adaptive therapy solutions (20.10.2022)

04/10/2022 IBA - ElsMed, Novatec and IBA sign contract to install radiopharmaceutical production center in Georgia (04.10.2022)

22/09/2022 IBA - and SCK CEN launch Pantera, a joint-venture to produce actinium-225 (22.09.2022)

20/09/2022 IBA - NorthStar Medical Radioisotopes and IBA Sign Agreement for Two Additional Rhodotron® Accelerators for Commercial Production of Radioisotopes (20.09.2022)

31/08/2022 IBA - Reports Half Year 2022 Results (31.08.2022)

30/08/2022 IBA - and CNRT sign collaboration agreement to install a Cyclone® IKON in China (30.08.2022)

30/08/2022 IBA - and ScandiDos form strategic alliance to increase access to safe radiotherapy (30.08.2022)

26/08/2022 IBA - qualifies as the only supplier for second round of tender to provide ten proton therapy units across Spain (26.08.2022)

18/08/2022 IBA - Fred Hutchinson Cancer Center and the University of Washington engage in a bench-to-bedside research program for FLASH Proton Therapy (18.08.2022)

02/08/2022 IBA - Fred Hutchinson Cancer Center and the University of Washington engage in a bench-to-bedside research program for FLASH Proton Therapy / Half year Results 2002 (02.08.2022)

30/06/2022 IBA - signs contract with Istituto Clinico Humanitas for a Proteus®ONE proton therapy solution in Italy (30.06.2022)

01/06/2022 IBA - signs Proteus®ONE contract with Baptist Health’s Lynn Cancer Institute for a new proton therapy center in South Florida, USA (1.06.2022)

19/05/2022 IBA - Business Update – First Quarter 2022 (19.05.2022)

05/05/2022 IBA - Receives Order from CGNNT for a Proteus®PLUS System to be Installed in Yangzhou, China (05.05.2022)

03/05/2022 IBA - Strengthens its Dosimetry Portfolio with Acquisition of Modus Medical Devices Inc. (03.05.2022)

06/04/2022 IBA - and UMC Groningen engage in FLASH irradiation research collaboration for breast cancer (06.04.2022)

24/03/2022 IBA - Reports Full Year 2021 Results (24.03.2022)

15/03/2022 IBA - en Tractebel kondigen partnerschap aan om bouwprojecten voor protontherapie te ondersteunen (15.3.2022)

14/02/2022 IBA - en SOGAZ Insurance Group ondertekenen contract voor Proteus®ONE protontherapie-oplossing in Rusland (14.02.2022)

07/02/2022 IBA – Aandelen inkoopprogramma (07.02.2022)

01/02/2022 IBA - TUSSENTIJDSE VERKLARING VOOR PUBLICATIE VAN DE RESULTATEN 2021 (01.02.2022)

26/01/2022 IBA - lanceert Compact Low-Energy Cyclotron, Cyclone® KEY (26.01.2022)

20/01/2022 IBA - and Mercury Plastics sign contract to install an irradiation cross-linking solution using IBA’s Rhodotron® technology in Ohio, USA (20.01.2022)

23/12/2021 IBA en Proton International ondertekenen contract voor Proteus®ONE Proton Therapy-oplossing in Arkansas, VS (23.12.2021)

19/11/2021 IBA - and NorthStar Medical Radioisotopes Sign Contract for Rhodotron® Electron Beam Accelerator for Commercial Production of Therapeutic Radioisotope Actinium-225 (Ac-225) (19.11.2021)

18/11/2021 IBA BUSINESS UPDATE – THIRD QUARTER 2021 (18.11.2021)

28/10/2021 IBA - en TRAD Tests & Radiations kondigen samenwerking aan om de volgende generatie stralingsverwerkingsapplicatie te ontwikkelen (28.10.2021)

25/10/2021 IBA - en de Universiteit van Pennsylvania werken samen om onderzoek naar ConformalFLASH®-therapie vooruit te helpen (25.10.2021)

20/10/2021 IBA - lanceert 's werelds eerste online protontherapieplatform (20.10.2021)

25/08/2021 IBA - Reports Half Year 2021 Results - 25% SALES GROWTH AND STRONG IMPROVEMENT IN REBIT LINKED TO INCREASED ACTIVITY AND ACCELERATED BACKLOG CONVERSION (25.08.2021)

10/06/2021 IBA - lanceert veelzijdige, nieuwe cyclotron met hoge energie (10.06.2021)

01/06/2021 IBA - initiates global DynamicARC® Consortium for the roll-out of Proton Arc Therapy (01.06.2021)

20/05/2021 IBA - Business Update – First Quarter 2021 (20.05.2021)

07/04/2021 IBA - Proteus®ONE selected by Advocate Radiation Oncology for new proton therapy center in Florida (08.04.2021)

25/03/2021 IBA - Reports Full Year 2020 Results (25.03.2021)

21/01/2021 IBA - Y20 Trading update (21.01.2021)

19/11/2020 IBA - Business Update – Third Quarter 2020 (19.11.2020)

06/10/2020 IBA - will install the first E-beam & X-ray system for industrial irradiation applications in Taiwan (6.10.2020)

24/09/2020 IBA - First payment of EUR 20 million received for strategic licensing deal in China (24.9.2020)

01/09/2020 IBA - announces strategic licensing deal for ProteusPLUS in China worth a minimum of EUR 100 million (1.9.2020)

01/09/2020 Biocartis - Expands Collaboration with LifeArc (1.9.2020)

26/08/2020 IBA - HY 2020 RESULTS – AMENDMENT TO TIMING OF PUBLICATION (26.8.2020)

26/08/2020 IBA - announces strategic licensing deal for Proteus®PLUS in China worth a minimum of EUR 100 million (26.8.2020)

26/08/2020 IBA - Reports Half Year 2020 Results '26.8.2020)

25/08/2020 IBA - appoints Dr. Richard Hausmann and Christine Dubus as Non-Executive Directors (25.8.2020)

13/05/2020 IBA - Business Update – First Quarter 2020 (13.5.2020)

26/03/2020 IBA - Reports Full Year 2019 Results (26.3.2020)

28/01/2020 IBA signs contract to install Georgia’s first proton therapy center (28.1.2020)

17/12/2019 IBA - sells RadioMed, part of IBA Dosimetry, to IZI Medical Products (17.12.2019)

22/08/2019 IBA - Halfjaarresultaten 2019 (22.8.2019)

29/07/2019 IBA - Notice of Half Year 2019 Results and Conference Call (29.7.2019)

09/07/2019 IBA - signs contract to install proton therapy center in Kansas, USA (9.7.2019)

08/05/2019 IBA - business update Q1 2019 (8.5.2019)

29/03/2019 IBA SELLS FIRST TWO RHODOTRON® ACCELERATORS TO NORTHSTAR MEDICAL RADIOISOTOPES (29.3.2019)

29/03/2019 IBA Selected to Install Five-room Proton Therapy System in Shenzhen, China (29.3.2019)

21/03/2019 IBA Reports Full Year 2018 Results (21.3.2019)

26/02/2019 IBA-Return to net profitability in H2 (26.2.2019)

21/12/2018 IBA to install a proton therapy solution in Charleroi, Belgium, and Dosimetry update (21.12.2018)

15/11/2018 IBA_bussiness update Q3 (15.11.2018)

30/08/2018 IBA and Parkway Pantai sign contract to install proton therapy system in Singapore (30.8.2018)

23/08/2018 IBA Reports Half Year Results for 2018 (23.8.2018)

30/05/2018 IBA: tankt vertrouwen bij (KBC)

22/03/2018 IBA (Jefferies)

05/07/2017 IBA: Forse winstwaarschuwing door vertraging uitvoering projecten en hogere kosten (BNP Paribas Fortis Wealth Outlook)